NL178316C - METHOD FOR PREPARING MEDICINES WITH GOOD INFLUENCE ON BLOOD CIRCUMSTICS AND METHOD FOR PREPARING MEDICINAL COMPOSITIONS SUITABLE THEREFOR. - Google Patents

METHOD FOR PREPARING MEDICINES WITH GOOD INFLUENCE ON BLOOD CIRCUMSTICS AND METHOD FOR PREPARING MEDICINAL COMPOSITIONS SUITABLE THEREFOR.

Info

Publication number
NL178316C
NL178316C NLAANVRAGE8302612,A NL8302612A NL178316C NL 178316 C NL178316 C NL 178316C NL 8302612 A NL8302612 A NL 8302612A NL 178316 C NL178316 C NL 178316C
Authority
NL
Netherlands
Prior art keywords
preparing
circumstics
blood
compositions suitable
medicinal compositions
Prior art date
Application number
NLAANVRAGE8302612,A
Other languages
Dutch (nl)
Other versions
NL178316B (en
NL8302612A (en
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB4238774A external-priority patent/GB1519147A/en
Priority claimed from FR7502307A external-priority patent/FR2258846A1/en
Priority claimed from NL7511452A external-priority patent/NL176776C/en
Application filed by Lafon Labor filed Critical Lafon Labor
Priority to NLAANVRAGE8302612,A priority Critical patent/NL178316C/en
Publication of NL8302612A publication Critical patent/NL8302612A/en
Publication of NL178316B publication Critical patent/NL178316B/en
Application granted granted Critical
Publication of NL178316C publication Critical patent/NL178316C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE8302612,A 1974-09-30 1983-07-21 METHOD FOR PREPARING MEDICINES WITH GOOD INFLUENCE ON BLOOD CIRCUMSTICS AND METHOD FOR PREPARING MEDICINAL COMPOSITIONS SUITABLE THEREFOR. NL178316C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE8302612,A NL178316C (en) 1974-09-30 1983-07-21 METHOD FOR PREPARING MEDICINES WITH GOOD INFLUENCE ON BLOOD CIRCUMSTICS AND METHOD FOR PREPARING MEDICINAL COMPOSITIONS SUITABLE THEREFOR.

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB4238774 1974-09-30
GB4238774A GB1519147A (en) 1974-09-30 1974-09-30 Sulphur and oxygen-containing diaryl compounds
GB158775 1975-01-14
GB158775 1975-01-14
FR7502307A FR2258846A1 (en) 1974-01-25 1975-01-24 Bis((N-hydroxy alkyl)-amino alkyl thio)alkane and derivs - as agents preventing blood platelet aggregation
FR7502307 1975-01-24
NL7511452 1975-09-29
NL7511452A NL176776C (en) 1974-09-30 1975-09-29 METHOD FOR PREPARING MEDICINES WITH BLOOD PLATE AGGREGATION INHIBITING AND SERUM LIPID RESP. SERUM CHOLESTEROL MIRROR LOWERING ACTIVITY, AND METHOD FOR PREPARING APPROPRIATE MEDICINE COMPOUNDS.
NLAANVRAGE8302612,A NL178316C (en) 1974-09-30 1983-07-21 METHOD FOR PREPARING MEDICINES WITH GOOD INFLUENCE ON BLOOD CIRCUMSTICS AND METHOD FOR PREPARING MEDICINAL COMPOSITIONS SUITABLE THEREFOR.
NL8302612 1983-07-21

Publications (3)

Publication Number Publication Date
NL8302612A NL8302612A (en) 1983-11-01
NL178316B NL178316B (en) 1985-10-01
NL178316C true NL178316C (en) 1986-03-03

Family

ID=27446285

Family Applications (3)

Application Number Title Priority Date Filing Date
NLAANVRAGE8302612,A NL178316C (en) 1974-09-30 1983-07-21 METHOD FOR PREPARING MEDICINES WITH GOOD INFLUENCE ON BLOOD CIRCUMSTICS AND METHOD FOR PREPARING MEDICINAL COMPOSITIONS SUITABLE THEREFOR.
NLAANVRAGE8302613,A NL178964C (en) 1974-09-30 1983-07-21 METHOD FOR PREPARING MEDICINES WITH GOOD INFLUENCE ON BLOOD CIRCUMSTICS AND METHOD FOR PREPARING MEDICINAL COMPOSITIONS SUITABLE THEREFOR.
NLAANVRAGE8302611,A NL178418C (en) 1974-09-30 1983-07-21 METHOD FOR PREPARING PHENYL ETHERS CONTAINING MEDICINES WITH FAVORABLE INFLUENCE ON BLOOD CIRCULATION AND SUITABLE COMPOUNDS

Family Applications After (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE8302613,A NL178964C (en) 1974-09-30 1983-07-21 METHOD FOR PREPARING MEDICINES WITH GOOD INFLUENCE ON BLOOD CIRCUMSTICS AND METHOD FOR PREPARING MEDICINAL COMPOSITIONS SUITABLE THEREFOR.
NLAANVRAGE8302611,A NL178418C (en) 1974-09-30 1983-07-21 METHOD FOR PREPARING PHENYL ETHERS CONTAINING MEDICINES WITH FAVORABLE INFLUENCE ON BLOOD CIRCULATION AND SUITABLE COMPOUNDS

Country Status (1)

Country Link
NL (3) NL178316C (en)

Also Published As

Publication number Publication date
NL178964B (en) 1986-01-16
NL178316B (en) 1985-10-01
NL8302611A (en) 1983-11-01
NL178418C (en) 1986-03-17
NL178964C (en) 1986-06-16
NL8302612A (en) 1983-11-01
NL8302613A (en) 1983-11-01
NL178418B (en) 1985-10-16

Similar Documents

Publication Publication Date Title
NL182369C (en) METHOD FOR PREPARING AN ORAL EXTENDED MEDICINE PREPARATION
NL182008C (en) METHOD FOR PREPARING AN ANTIBIOTIC AND METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THIS ANTIBIOTIC
NL177405C (en) METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS AND METHOD FOR PREPARING MEDICINAL COMPOUNDS, SUITABLE FOR USE IN THESE PREPARATIONS.
NL7513985A (en) PROCEDURE FOR PREPARING AN ANTIVIRAL PREPARATION AND PREPARATION SUCHED.
NL191793B (en) Method for the preparation of a polypeptide, and of a pharmaceutical or veterinary preparation.
NL177021C (en) METHOD FOR PREPARING MEDICINES WITH ANTIBIOTIC ACTIVITY AND MEDICINE COMPOUNDS SUITABLE FOR THAT.
NL170144C (en) METHOD FOR PREPARING AN ANTHELMINTIC PREPARATION AND AN ACTIVE SUBSTANCE SUITABLE THEREFOR.
NL168822C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH CARDIOTONIC AND BLOOD SUGAR REDUCING EFFECT.
NL162072C (en) METHOD FOR PREPARING PAIN-RELIEF ANTI-NARCOTIC MEDICINAL PRODUCTS, SO PREPARED MEDICINAL PRODUCTS, AND METHOD FOR PREPARING SUITABLE SUBSTANCES THEREFOR.
NL166939C (en) METHOD FOR PREPARING MEDICINAL PRODUCTS WITH FAVORABLE BLOOD INFLUENCE AND METHOD FOR PREPARING SUITABLE COMPOUNDS
NL176853C (en) METHOD FOR PREPARING 2-ARYLAMINO-2-IMIDAZOLINE DERIVATIVES, WITH AN ANTI-BLOOD EFFECT, AND MEDICINES THEREOF
NL163515C (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION AND FOR PREPARING ANY ACTIVE SUBSTANCE PRESENT IN IT, SUBSTITUTED 6-ARYL-4H-S-TRIAZOLO-Ÿ3,4CŸ-THIENO-Ÿ2,3EŸ-1,4- - DIAZEPINE.
NL7512489A (en) METHOD FOR PREPARING ANTITUMORGLYCOSIDE MEDICINAL PRODUCTS.
NL7514970A (en) PROCEDURE FOR PREPARING A MEDICINAL PRODUCT, SUCH MEDICINAL PRODUCT AND PROCEDURE FOR PREPARING SUITABLE ACTIVE COMPONENTS.
NL7509469A (en) PROCESS FOR PREPARING AN ORAL PREPARATION.
NL181408B (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTI-ALLERGY EFFECT, AND METHOD FOR PREPARING USE THEREOF 5-SUBSTITUTED 1H-TETRAZOLE DERIVATIVES.
NL157655B (en) METHOD FOR PREPARING AN ANTIBIOTIC AND ANTIBIOTIC PREPARATIONS, AND FORMED MEDICINAL OR DISINFECTANT.
NL7412254A (en) METHOD FOR PREPARING AN ORAL PREPARATION AGAINST DIABETES.
NL172120C (en) METHOD FOR PREPARING A PHARMACEUTICAL OR VETERINARY PREPARATION
NL180072C (en) DEVICE FOR DIALYZING BLOOD.
NL178964C (en) METHOD FOR PREPARING MEDICINES WITH GOOD INFLUENCE ON BLOOD CIRCUMSTICS AND METHOD FOR PREPARING MEDICINAL COMPOSITIONS SUITABLE THEREFOR.
NL7503630A (en) PROCEDURE FOR PREPARING 1-ARYLURACILES AND ITS USE AS A MEDICINAL PRODUCT.
NL163220C (en) PROCESS FOR PREPARING A CO-R COBAMIDE, AND PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING PREPARED CO-R-COBAMIDE
NL178255C (en) METHOD FOR THE PREPARATION OF ARYLOXYPROPYLPIPERAZINE DERIVATIVES, PRODUCTS MADE WITH THESE METHOD AND METHOD FOR THE PREPARATION OF PREPARATIONS CONTAINING THEM.
NL175995C (en) METHOD FOR PREPARING ANTI-ALLERGIC MEDICINAL PRODUCTS AND THE ACTIVE SUBSTANCES SUITABLE THEREFOR.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V4 Lapsed because of reaching the maximum lifetime of a patent

Free format text: 950929